Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. (mở cửa sổ mới)

Antun AG, Gleason S, Arellano M, Langston AA, McLemore ML, Gaddh M, el Rassi F, Bernal-Mizrachi L, Galipeau J, Heffner LT Jr, Winton EF, Khoury HJ.

Nguồn‎: Cancer 2013;119(21):3784-7.

Mã bài‎: PubMed 23921838

DOI‎: 10.1002/cncr.28253

https://www.ncbi.nlm.nih.gov/pubmed/23921838 (mở cửa sổ mới)

Low dose bolus aminocaproic acid: an alternative to platelet transfusion in thrombocytopenia? (mở cửa sổ mới)

Chakrabarti S, Varma S, Singh S, Kumari S

Nguồn‎: Eur J Haematol 1998;60(5):313-4.

Mã bài‎: PubMed 9654162

DOI‎: 10.1111/j.1600-0609.1998.tb01046.x

https://www.ncbi.nlm.nih.gov/pubmed/9654162 (mở cửa sổ mới)

The use of antifibrinolytics in pediatric patients with hypoproliferative thrombocytopenia. (mở cửa sổ mới)

Delaney M, Matthews DC, Gernsheimer TB

Nguồn‎: Pediatr Blood Cancer 2017;64(12):e26641.

Mã bài‎: PubMed 28544698

DOI‎: 10.1002/pbc.26641

https://www.ncbi.nlm.nih.gov/pubmed/28544698 (mở cửa sổ mới)

Preliminary experience with epsilon aminocaproic acid for treatment of intractable upper tract hematuria in children with hematological disorders. (mở cửa sổ mới)

Kaye JD, Smith EA, Kirsch AJ, Cerwinka WH, Elmore JM

Nguồn‎: J Urol 2010;184(3):1152-7.

Mã bài‎: PubMed 20650477

DOI‎: 10.1016/j.juro.2010.05.020

https://www.ncbi.nlm.nih.gov/pubmed/20650477 (mở cửa sổ mới)

A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. (mở cửa sổ mới)

Shpilberg O, Blumenthal R, Sofer O, Katz Y, Chetrit A, Ramot B, Eldor A, Ben-Bassat I.

Nguồn‎: Leuk Lymphoma 1995;19(1-2):141-4.

Mã bài‎: PubMed 8574160

DOI‎: 10.3109/10428199509059668

https://www.ncbi.nlm.nih.gov/pubmed/8574160 (mở cửa sổ mới)

Pediatric off-label use of recombinant factor VIIa. (mở cửa sổ mới)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

Nguồn‎: Pediatrics 2009;123(3):1066-72.

Mã bài‎: PubMed 19255041

DOI‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (mở cửa sổ mới)

Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience. (mở cửa sổ mới)

Bhat S, Yadav SP, Anjan M, Dinand V, Sachdeva A.

Nguồn‎: Indian J Pediatr 2011;78(8):961-8.

Mã bài‎: PubMed 21328080

DOI‎: 10.1007/s12098-011-0364-6

https://www.ncbi.nlm.nih.gov/pubmed/21328080 (mở cửa sổ mới)

Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated Factor VII. (mở cửa sổ mới)

Brenner B, Hoffman R, Balashov D, Shutluko E, Čulić SD, Nizamoutdinova E.

Nguồn‎: Clin Appl Thromb Hemost 2005;11(4):401-10.

Mã bài‎: PubMed 16244765

https://www.ncbi.nlm.nih.gov/pubmed/16244765 (mở cửa sổ mới)

Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label. (mở cửa sổ mới)

Croteau SE, Nakar C, Neufeld EJ, Shapiro A, Cooper DL

Nguồn‎: Pediatr Blood Cancer 2016;63(10):1822-8.

Mã bài‎: PubMed 27232114

DOI‎: 10.1002/pbc.26082

https://www.ncbi.nlm.nih.gov/pubmed/27232114 (mở cửa sổ mới)

Use of recombinant factor VIIa prior to lumbar puncture in pediatric patients with acute leukemia. (mở cửa sổ mới)

Das P, Carcao M, Hitzler J

Nguồn‎: Pediatr Blood Cancer 2006;47(2):206-9.

Mã bài‎: PubMed 16007583

DOI‎: 10.1002/pbc.20467

https://www.ncbi.nlm.nih.gov/pubmed/16007583 (mở cửa sổ mới)

A comprehensive review of rFVIIa use in a tertiary care pediatric center. (mở cửa sổ mới)

Heller M, Lau W, Pazmino-Canizares J, Brandão LR, Carcao M

Nguồn‎: Pediatr Blood Cancer 2008;50(5):1013-7.

Mã bài‎: PubMed 17960639

DOI‎: 10.1002/pbc.21375

https://www.ncbi.nlm.nih.gov/pubmed/17960639 (mở cửa sổ mới)

Recombinant activated factor VII for severe gastrointestinal bleeding after chemotherapy in an infant with acute megakaryoblastic leukemia. (mở cửa sổ mới)

Kurekci AE, Atay AA, Okutan V, Yavuz ST, Ozcan O

Nguồn‎: Blood Coagul Fibrinolysis 2005;16(2):145-7.

Mã bài‎: PubMed 15741803

DOI‎: 10.1097/01.mbc.0000161569.66764.70

https://www.ncbi.nlm.nih.gov/pubmed/15741803 (mở cửa sổ mới)

Off-label use of recombinant factor VIIa in pediatric patients. (mở cửa sổ mới)

McQuilten ZK, Barnes C, Zatta A, Phillips LE; Haemostasis Registry Steering Committee

Nguồn‎: Pediatrics 2012;129(6):e1533-40.

Mã bài‎: PubMed 22641758

DOI‎: 10.1542/peds.2011-2561

https://www.ncbi.nlm.nih.gov/pubmed/22641758 (mở cửa sổ mới)

Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: the experience of the Hemostasis and Thrombosis Research Society (HTRS) registry (2004-2008). (mở cửa sổ mới)

Neufeld EJ, Saxena K, Kessler CM, Cooper DL; HTRS Investigators

Nguồn‎: Pediatr Blood Cancer 2013;60(7):1178-83.

Mã bài‎: PubMed 23335449

DOI‎: 10.1002/pbc.24472

https://www.ncbi.nlm.nih.gov/pubmed/23335449 (mở cửa sổ mới)

Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII: report on one case and review of other uses in acute leukemias. (mở cửa sổ mới)

Pamuk GE, Taşçi M, Oztürk E, Demir M.

Nguồn‎: Med Oncol 2010;27(1):16-9.

Mã bài‎: PubMed 19137431

DOI‎: 10.1007/s12032-008-9163-y

https://www.ncbi.nlm.nih.gov/pubmed/19137431 (mở cửa sổ mới)

Successful treatment of acute lymphoblastic leukemia with l-asparaginase-induced intracranial hemorrhage to activated recombinant factor VIIa in a child. (mở cửa sổ mới)

Ucar C, Caliskan U

Nguồn‎: Pediatr Hematol Oncol 2006;23(4):339-45.

Mã bài‎: PubMed 16621776

DOI‎: 10.1080/08880010600631987

https://www.ncbi.nlm.nih.gov/pubmed/16621776 (mở cửa sổ mới)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (mở cửa sổ mới)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

Nguồn‎: Pediatr Hematol Oncol 2008;25(4):301-11.

Mã bài‎: PubMed 18484474

DOI‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (mở cửa sổ mới)

The use of DDAVP in children with bleeding disorders. (mở cửa sổ mới)

Ben-Ami T, Revel-Vilk S

Nguồn‎: Pediatr Blood Cancer 2013;60 Suppl 1:S41-3.

Mã bài‎: PubMed 23109357

DOI‎: 10.1002/pbc.24335

https://www.ncbi.nlm.nih.gov/pubmed/23109357 (mở cửa sổ mới)

Treatment of refractory thrombocytopenic bleeding with 1-desamino-8-D-arginine vasopressin (desmopressin). (mở cửa sổ mới)

Kobrinsky NL, Tulloch H

Nguồn‎: J Pediatr 1988;112(6):993-6.

Mã bài‎: PubMed 3373409

DOI‎: 10.1016/s0022-3476(88)80234-8

https://www.ncbi.nlm.nih.gov/pubmed/3373409 (mở cửa sổ mới)

The use of Tachosil as hemostatic sealant in nephron sparing surgery for Wilms tumor: preliminary observations. (mở cửa sổ mới)

Mele E, Ceccanti S, Schiavetti A, Bosco S, Masselli G, Cozzi DA

Nguồn‎: J Pediatr Surg 2013;48(3):689-94.

Mã bài‎: PubMed 23480936

DOI‎: 10.1016/j.jpedsurg.2013.01.019

https://www.ncbi.nlm.nih.gov/pubmed/23480936 (mở cửa sổ mới)